Please login to the form below

Not currently logged in
Email:
Password:

Emergency drug fund for cancer patients

The UK government has announced a £50m fund allowing patients access to cancer drugs up to six months earlier than would otherwise be possible

The UK government has announced a £50m fund aimed at giving patients access to cancer drugs recommended by a hospital doctor up to six months earlier than would otherwise be possible.

MPs have agreed to introduce the interim fund to pay for such medication, even if it has not been approved by the National Institute for Health and Clinical Excellence (NICE), from October 2010. It means cancer patients will be able to access new medication, available elsewhere in Europe, immediately to help extend or better the quality of their lives.

The move follows findings that Britain lags behind other countries when it comes to new drug provision, as well as pressure from campaigners who questioned why the fund that had been due to come in force in April 2010 could not be made available immediately.

The interim fund will be paid for from undisclosed savings in the health budget. Doctors and cancer specialists will decide how the fund is spent for their patients locally.

The announcement comes in the wake of Nikki Phelps' death, a terminally ill mother who had been denied NHS funding for life-prolonging drugs. Her case was raised by Prime Minister David Cameron during the election campaign after she said she was going to sell her house to pay for the drug. She died a week after the election.

Health Secretary Andrew Lansley said: "It's a scandal that we are strong in cancer research and participation in clinical trials in the UK, yet NHS patients aren't always seeing the benefits from the research swiftly enough.

"Patients should have access to innovative cancer drugs that can extend or improve their quality of life and which their doctors have recommended, which is why I'm determined to take action now."

27th July 2010

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics